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the selective GABACR antagonist (1,2,5,6-tetrahydropyridine-4-yl) 
methylphosphinic acid (TPMPA), facilitates learning and memory 
in the Morris Water Maze task in mice (Chebib et al., 2009).
GABACR-speciﬁ  c ρ1 and ρ2 subunits were detected in the 
amygdala of mice using in situ-hybridization [Allen Brain Atlas 
(Internet)]. Functional GABACR have been identiﬁ  ed in several 
regions of the nervous system (Johnston et al., 1975; Lukasiewicz 
et al., 1994; Pan and Lipton, 1995; Delaney and Sah, 1999; Boller and 
Schmidt, 2001, 2003; Kirischuk et al., 2003; Hartmann et al., 2004), 
including the lateral part of the central nucleus of the amygdala 
(CE; Delaney and Sah, 1999), but have not been reported in the LA. 
Demonstration of the existence of GABACRs in the LA and deter-
mining their role in amygdala circuitry could lead to a better under-
standing of inhibitory plasticity in this brain region. Furthermore, 
GABACRs could be an important target in the effort to develop 
pharmacological treatments for anxiety-related disorders since, 
unlike GABAARs, GABACRs do not desensitize (Bormann, 2000).
The goals of the current study were to verify the expression of 
functional GABACR in the LA, and to analyze their role in circuitry 
using whole-cell patch clamp recordings in acute slices in vitro. To 
examine the relevance of the role of GABACRs on fear learning and 
memory, we performed in vivo auditory Pavlovian fear condition-
ing a learning paradigm in which an emotionally neutral auditory 
conditioned stimulus (CS) comes to elicit fear responses after it is 
paired with an aversive unconditioned stimulus (US). Because fear 
conditioning is rapidly acquired and long lasting and the neural 
circuits underlying the learning are well understood and known 
INTRODUCTION
The lateral nucleus of the amygdala (LA) is a key site of plasticity 
underlying fear learning (LeDoux, 2000; Blair et al., 2001; Maren 
and Quirk, 2004), and inhibitory circuits in that structure play an 
important role in the regulation of fear memory and its extinc-
tion (Wilensky et al., 1999; Akirav and Richter-Levin, 2006; Zhang 
and Cranney, 2008). In the mammalian brain, γ-aminobutyric acid 
(GABA) is the most abundant inhibitory neurotransmitter (Nicoll 
et al., 1990). It acts through different receptor types, including the 
ionotropic GABAA (GABAAR) and GABAC (GABACR) receptors 
(both of which activate Cl− currents), and the metabotropic GABAB 
receptor (GABABR). Most studies that have examined the role of 
GABA receptors in the LA have focused on GABAARs. GABAARs 
and GABACRs are activated by the same ligands (GABA or GABAA 
agonists; Lukasiewicz et al., 1994), but GABACRs are many times 
more sensitive than GABAARs to these. If GABACRs are present 
in the LA, they should thus contribute to amygdala functions 
under different conditions than GABAARs. To test this, we used 
different concentrations of the GABA agonist muscimol since low 
concentrations should activate GABACRs and high concentrations 
GABAARs.
The functional signiﬁ  cance of GABACRs is generally less well 
understood than that of the other GABARs, and few studies have 
explored the contribution of GABACRs to learning, memory and 
plasticity. Research performed in chicks found GABAARs and 
GABACRs in the forebrain play opposite roles in short-term mem-
ory (STM) of avoidance learning (Gibbs and Johnston, 2005). Also, 
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to critically involve the LA, fear conditioning has been a popular 
technique for exploring the cellular and molecular mechanisms 




All animal experiments were performed in accordance with 
our institutional guidelines after obtaining the approval of the 
Institutional Animal Care and Use Committee (IACUC). For the 
electrophysiological experiments we received 37 Sprague Dawley 
21-day-old rats. For the behavioral experiments we received 28 
naïve male Sprague Dawley rats, weighing 250–300 g. These rats 
were housed individually and placed on a 12-h light/dark cycle with 
ad libitum food and water. The rats were acclimatized to laboratory 
conditions for 3 days before undergoing surgery.
ELECTROPHYSIOLOGICAL EXPERIMENTS
Slice preparations
The amygdala slice preparation has been described previously 
(Weisskopf et al., 1999). Rats were anesthetized with subcutaneous 
injection of ketamine (100 mg/kg body weight) and thiazine hydro-
chloride (1 mg/kg). To obtain acute slices of the LA for recording, 
the rats were deeply anesthetized with a subcutaneous injection 
of ketamine (100 mg/kg body weight) and thiazine hydrochloride 
(1  mg/kg). After transcardial perfusion with ice-cold artiﬁ  cial 
 cerebro-spinal ﬂ  uid (ACSF) containing (in mM), NaCl 124, KCl 5, 
NaH2PO4 1.25, NaHCO3 26, MgSO4 2, CaCl2 2, glucose 10, that was 
continuously gassed with 5% CO2/95% O2, the brain was removed 
and cut into 300 µm thick sagittal slices on a vibratome in ice cold 
ACFS. To allow recovery, slices were incubated for 1 h in ACSF at a 
temperature of 36°C. For recording, the slices were transferred into 
a submerged type recording chamber where they were continuously 
superfused at 3 ml/min with ACSF at room temperature.
Electrophysiology
For whole-cell recordings, slices were transferred to a submersion-
type recording chamber where they were continuously perfused 
with oxygenated ACSF at a rate of 4 ml/min. Whole-cell recordings 
were obtained from the pyramidal cells in the LA region. Patch elec-
trodes were fabricated from borosilicate glass and had a resistance 
of 5.0–8.0 MΩ. The pipettes were ﬁ  lled with internal solution com-
posed of (in mM): potassium gluconate, 130; sodium gluconate, 2; 
HEPES, 20; MgCl2, 4; Na2ATP, 4; NaGTP, 0.4; EGTA, 0.5. In order 
to block sodium spikes, 5 mM QX 314 (Sigma-Aldrich) was added, 
as was 0.5% biocytin for morphological single cell reconstruction. 
Neurons were visualized with an upright microscope (Nikon Eclipse 
E600fn) using the Nomarski-type differential interference optics 
through a 60× water immersion objective. Neurons with a pyrami-
dal appearance were selected for recordings. Neurons were voltage 
clamped using an Axopatch 200B ampliﬁ  er (Axon Instruments, 
Foster City, CA, USA). Excitatory (EPSCs) and inhibitory post-
synaptic currents (IPSCs) were recorded at a holding potential of 
−35 mV. Synaptic responses were evoked with sharpened tungsten 
bipolar stimulating electrodes (2 mm diameter, World Precision 
Instruments, Sarasota, FL, USA) placed in the cortical and thalamic 
pathway, 50–100 mm from the recording electrode. Stimulation 
was applied, at 0.1 Hz, using a photoelectric stimulus isolation 
unit having a constant current output (PSIU6, Grass Instrument 
Co., West Warwick, RI, USA). Access resistance (8–26 MΩ) was 
regularly monitored during recordings, and cells were rejected if 
it changed by more than 15% during the experiment. The signals 
were ﬁ  ltered at 2 kHz, digitized (Digidata 1440A, Axon Instruments, 
Inc.), and stored on a computer using the pCLAMP10.2 software 
(Axon Instruments, Inc.). The peak amplitude, 10–90% rise time, 
and the decay time constant of IPSCs were analyzed off-line using 
pCLAMP10.2 software (Axon Instruments).
Drugs
All pharmacologically active substances were bath applied for 10 min 
to achieve stable responses before their effects were tested. We used 
0.1 µM muscimol (C5-aminomethyl acid; Sigma) as GABACR ago-
nist. To make sure that the evoked responses were not GABAAR-
mediated 20 µM bicuculline (GABAAR antagonist; Sigma) was 
co-applied. GABACRs were blocked with 30 µM TPMPA (Sigma). 
As GABABR agonist we applied 50 µM CGP52432 (Tocris).
Paired pulse depression
Neurons were stimulated by using an interstimulus interval of 
100 ms. EPSCs and IPSCs were recorded.
Histochemistry
After each recording session, slices were immersion ﬁ  xed in 4% para-
formaldehyde in 0.1 M phosphate buffer, pH 7.4, at 4°C for 24 h. 
The slices were processed using standard histochemical techniques 
for visualization of biocytin with 3,3-diaminobenzidine (Sigma-
Aldrich). For documentation, stained cells were photographed using 
a digital camera attached to a standard laboratory microscope.
Analysis
Data were analyzed by paired Student’s t-tests, because one 




Rats were anesthetized with subcutaneous injection of ketamine 
(100 mg/kg body weight) and thiazine hydrochloride (1 mg/kg) 
and treated with atropine sulfate (0.4 mg/kg). Using a stereotaxic 
frame, guide cannulae (22 gauge; Plastics One, Roanoke, VA, USA) 
ﬁ  tted with internal cannulae that extended out by 1.5 mm were 
positioned just above the lateral and basal amygdala (LBA) using 
coordinates 3 mm posterior to bregma, 7.2 mm ventral to skull sur-
face, and 5.5 mm lateral to midline). The guide cannulae were ﬁ  xed 
to screws in the skull using cranioplastic cement (Plastics One). 
After the cement hardened, internal cannulae were replaced with 
dummy cannulae, cut 0.5 mm longer than the guides, to prevent 
clogging. Rats were tested the following week after recovery.
Intracranial injections
Rats were held in the experimenter’s lap while dummy cannulae 
were replaced with 28-gauge injector cannulae attached to 1.0 ml 
Hamilton syringes via polyurethane tubing. The tubing was back-
ﬁ  lled with distilled water, and a small air bubble separated the water Frontiers in Behavioral Neuroscience  www.frontiersin.org  March  2010 | Volume  4 | Article  6 | 3
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RESULTS
We recorded from 47 pyramidal cells across the LA. Input resist-
ances of recorded neurons in patch clamp experiments ranged from 
104.7 to 198.0 MΩ (mean 160.2 MΩ, SD 64.5), resting membrane 
potentials varied between −55.7 and −68.3 mV (mean −61.3 mV, 
SD 5.0).
EFFECTS OF MUSCIMOL ON POSTSYNAPTIC CURRENTS
In the ﬁ  rst experiments we used whole-cell patch clamp recordings 
in acute slices in vitro to test whether GABACRs are present and 
participate in synaptic transmission within the LA. To elicit post-
synaptic currents, electric stimulation was applied to the cortical or 
thalamic pathway to mimic, in vitro, testing the effects of stimulation 
of sensory inputs known to occur during fear conditioning in vivo 
(Romanski et al., 1993; Repa et al., 2001). The effects of the 1 µM 
muscimol, the GABA agonist, on the electrically evoked responses 
was assessed since this concentration has been reported to selec-
tively activate GABACRs as opposed to GABAARs (Pasternack et al., 
1999; Boller and Schmidt, 2001; Schmidt et al., 2001). To determine 
whether this 1 µM muscimol primarily activated GABACRs we also 
examined the effects of blockade of GABAARs and GABABRs on 
the electrically evoked responses by adding the GABAAR antagonist 
bicuculline and the GABABR antagonist CGP 52432 separately to 
the bath during recordings.
EPSCs and IPSCs, evoked through external and internal capsule 
stimulation, were recorded from 23 pyramidal cells. Application 
of 1 µM muscimol, the concentration selective for activation of 
GABACRs, led to a decrease of IPSCs by 84 ± 13.7% (p < 0.05) 
and an increase in EPSCs of 90  ± 21.5%  (p <  0.05) in all cells 
(Figures 1A,B). CGP 52432 the GABABR antagonist decreased inhi-
bition by 82 ± 9.9% (p < 0.05) and increased excitation 75 ± 7.1% 
(p < 0.05) in all pyramidal cells. Co-application of bicuculline to 
1 µM muscimol and CGP blocked all the IPSCs (100%, p < 0.05) and 
the excitatory current increased by additional 330 ± 82% (p < 0.05; 
Figure 1A). These results suggest that muscimol, in a concentration 
that selectively activates GABACRs, reduced inhibition in the LA and 
increased excitation. This is the opposite of the effects of activating 
GABAARs and GABABRs, which, upon ligand activation, hyperpolar-
ize pyramidal neurons and reduce excitation. Consistent with this, 
we found that GABAARs and GABABRs blockade led to reduction 
of evoked inhibition and increment of excitation.
EFFECTS OF GABACR ANTAGONISTS ON POSTSYNAPTIC CURRENTS
In the next set of experiments the effects of a blockade of GABACRs 
on the electrically evoked responses in pyramidal cells was exam-
ined (n = 14). The selective GABACR antagonist TPMPA was bath-
applied and led to enhancement of inhibition: IPSC amplitudes 
were increased (41  ± 18.2%,  p <  0.05), and EPSC amplitudes 
were reduced by 60 ± 26.7% (p < 0.05; Figures 1C,D). GABACRs 
are resistant to GABAAR antagonist bicuculline and GABABRs 
antagonist CGP 52432. We added bicuculline and CGP 52432 to 
TPMPA to verify that the recorded impact of TPMPA applications 
were a GABACR related effect. The IPSCs were completely blocked 
(100 ± 0%) in all 14 pyramidal cells, leading to increased EPSC 
amplitudes (350 ± 75%, p < 0.05; Figure 1C), so all inhibition was 
extinguished. Blocking GABAARs and GABABRs had the opposite 
effect of blocking GABACRs.
from the drug solution. The drug volume was 0.0003 ml that was 
infused bilaterally by an infusion pump at a rate of 0.05 µl/min. 
After drug infusion, cannulae were left in place for additional 3 min 
to allow diffusion of the drug away from the cannula tip, after which 
the dummy cannulae were replaced.
Apparatus
Fear conditioning took place in a Plexiglas rodent condition-
ing chamber with a metal grid ﬂ  oor (model E10-10; Coulbourn 
Instruments, Lehigh Valley, PA, USA), dimly illuminated by a single 
house light and enclosed within a sound-attenuating chamber 
(model E10-20). Testing for conditioned fear responses occurred 
in a brightly lit Plexiglas chamber with three house lights (ENV-
001; Med Associates Inc., Georgia, VT, USA), ﬁ  tted with a ﬂ  at 
black Formica ﬂ  oor that had been washed with a peppermint-
scented soap. Previous studies have shown that this distinct testing 
environment minimizes generalization from the training envi-
ronment (Nader and LeDoux, 1999; Schafe et al., 1999). A video 
camera mounted at the top of the chamber recorded behavior 
for later scoring.
Habituation, conditioning, and testing
Figure 2 shows the behavior procedure. On day 1, rats received 
either muscimol (0.03 nmol/side in 0.0003 ml), TPMPA (30 nmol/
side in 0.0003 ml) or ACSF vehicle (0.0003 ml) 60 min before train-
ing. All rats were habituated to the training and testing chambers 
for 10 min right before conditioning.
For training, rats were allowed 2–3 min to acclimate to the con-
ditioning chamber and were then presented with three pairings 
of a 20-s tone CS (5 kHz, 75 dB) that co-terminated with a foot 
shock US (0.5 s, 0.7 mA). The intertrial interval varied randomly 
between 90 and 120 s. After drug infusion and conditioning, rats 
were returned to their home cages and to the colony.
Testing took place for STM and long-term memory (LTM). The 
STM test consisted of two CSs presentations 3 h after condition-
ing and the LTM test 18 CS presentations 24 h after conditioning. 
Rats were videotaped during testing for later scoring. After a 3-min 
acclimation period to the test chamber, rats were presented with 20 s 
tones (5 kHz, 75 dB). After tone testing, rats were returned to their 
home cages and to the colony. Fear memory was evaluated from the 
videotape by measuring the number of seconds during each tone 
presentation where rats engaged in freezing behavior, deﬁ  ned as a 
lack of all movement with the exception of respiration.
Data were analyzed with the unpaired Student’s t-test, because 
two separate independent and identically distributed samples were 
obtained, where one from each of the two populations were com-
pared. Measures were compared by ANOVA with post hoc testing 
where appropriate (p < 0.05).
Histology
To verify injector tip location, rats were anesthetized with an over-
dose of Nembutal (100 mg/kg, i.p.) and perfused transcardially 
with 0.9% NaCl followed by 10% buffered Formalin. Brains were 
postﬁ  xed in 10% buffered Formalin and subsequently blocked, 
sectioned on a cryostat at 50 µm. Sections were cover slipped with 
Permount and examined under light microscopy for injector tip 
penetration into the amygdala.Frontiers in Behavioral Neuroscience  www.frontiersin.org  March  2010 | Volume  4 | Article  6 | 4
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Next we veriﬁ  ed that TPMPA application blocks the effect of 
muscimol. We applied just 1 µM muscimol to the bath for 15 min, 
and after this we added TPMPA (n = 10). One micromolar mus-
cimol led to a decrease of IPSCs by 86 ± 11.5% (p < 0.05) and an 
increase in EPSCs of 89 ± 11.9% (p < 0.05) in all cells. After the 
addition if TPMPA the effect of muscimol was completely blocked 
and IPSC amplitudes were increased (71 ± 10.6%, p < 0.05), and 
EPSC amplitudes were reduced by 84 ± 23.9% (p < 0.05).
In summary, our physiological studies show that blockade of 
GABACRs with TPMPA increases inhibition and their activation 
with 1 µM muscimol leads to the opposite. If the GABACRs were 
located on the postsynaptic side, we would have expected for mus-
cimol to increase inhibition and TPMPA enlarge excitation. The 
fact that muscimol lead to a decrease in inhibition and TPMPA 
to an increase in excitation. This suggests the possibility that the 
GABACRs are located on the presynaptic side. We next tested this 
hypothesis directly.
PAIRED PULSE DEPRESSION AND FACILITATION WAS AFFECTED BY 
MUSCIMOL AND TPMPA
Paired pulse depression (PPD) and facilitation (PPF) are tests of 
presynaptic effects. To examine whether GABACRs act on presy-
naptic sites, we used PPD and PPF of IPSCs and EPSCs by using 
an interstimulus interval of 100 ms. PPD of IPSCs is associated 
with decreased GABA release and a PPD of EPSCs with increased 
GABA release. In all 12 neurons recorded, TPMPA increased the 
PPD of EPSCs by 35.6 ± 7.3% (p < 0.05). Muscimol signiﬁ  cantly 
increased the PPD ratio and of IPSCs by 42.5 ± 5.2% (p < 0.05) 
and increased the PPF ratio of EPSCs by 39.2 ± 3.9% (p < 0.05) 
(Figure 2). These data support our hypothesis that GABACRs could 
be located on the presynaptic sites of GABAergic interneurons in 
the LA. Therefore, the function of GABACRs seems to be opposite 
from GABAARs and GABABRs in vitro. Based on these results we 
next asked the question, if this function of GABACRs would affect 
learning and memory abilities in the living animal.
BEHAVIORAL EFFECTS OF GABACR ACTIVATION
We tested whether GABACRs participate in fear learning and 
memory using auditory Pavlovian fear conditioning. Because 
our electrophysiological results showed that direct activation of 
GABACRs reduced evoked inhibition and enhanced excitation 
in LA pyramidal neurons, we hypothesized that stimulation of 
GABACRs in the LA prior to fear conditioning should enhance the 
acquisition of fear memory formation. To test this hypothesis, rats 
were chronically implanted with bilateral cannulae in the LA and 
muscimol or vehicle (ACSF) were injected in the LA in separate 
groups of animals prior to fear conditioning. Based on a previous 
study (Wilensky et al., 1999), where 4.4 nm muscimol was used to 
activate GABAARs, we used a very weak concentration (0.03 nM) 
of muscimol 1 h before FC (Figure 3). As noted GABACRs are at 
least 10-fold more sensitive to muscimol than GABAARs (Bormann, 
2000), and our concentration was more than 100 times less than 
that used in previous studies to block fear learning. We tested STM 
3 h after conditioning and LTM 24 h later. We analyzed pre-tone 
freezing, the average was 5 ± 0.3%, and there was no signiﬁ  cant 
difference between groups (p > 0.05).
FIGURE 1 | In vitro patch clamp recordings, showed functional GABACRs in 
the rat LA. (A) Recorded traces of a pyramidal cell in the LA during control, 
application of 1 µM muscimol (GABACR agonist), addition of 50 µM CGP 52432 
(GABABR antagonist), and co-application of 10 µM bicuculline (GABAAR 
antagonist). (B) Average effect of 1 µM muscimol on synaptic currents of 
pyramidal cells in the LA compared to Control (n = 23). (C) Traces of synaptic 
currents of a pyramidal cell in the LA under control conditions, application of 
30 µM TPMPA (GABACR agonist), 50 µM CGP 52432 (GABABR antagonist), and 
addition of bicuculline to CGP 52432. (D) Effect of 30 µM TPMPA on all recorded 
pyramidal cells in the LA compared to control (n = 14).Frontiers in Behavioral Neuroscience  www.frontiersin.org  March  2010 | Volume  4 | Article  6 | 5
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Figure 4A shows the mean ± SE percent freezing during the 
test tone presentations for rats injected before conditioning with 
0.03 nM muscimol (n = 6) and saline (n = 7). The results show a 
signiﬁ  cant difference between the saline and muscimol groups for 
FC (p < 0.05), STM (p < 0.05), and LTM (p < 0.05) (Figures 4A–C). 
Administration of 0.03 nM muscimol enhanced fear acquisition 
and consolidation.
BEHAVIORAL EFFECTS OF GABACR BLOCKADE
Because the electrophysiological data indicate that blocking 
GABACRs with TPMPA enhances evoked inhibition, we hypothe-
sized that blocking GABACRs with TPMPA would impair fear learn-
ing and memory in rats. As before, bilateral cannulae injections 
of 30 nM TPMPA (n = 7) into the LA were performed 1 h before 
FC whereas the control group received intra-LA administration of 
ACSF (n = 6) and both STM and LTM were assessed. In Figure 5A 
we show mean ± SE percent freezing levels for TPMPA and control 
treated animals, demonstrating that intra-LA microinjections of 
TPMPA signiﬁ  cantly impaired fear learning and memory at STM 
(p < 0.05) and LTM (p < 0.05) time points (Figures 5B–D).
HISTOLOGY
Histological reconstruction of cannulae placements revealed that 
all injector tips were located in the LA in 26 out of 47 animals and 
were thus included in the analysis.
DISCUSSION
Our results indicate that GABACRs are involved in intra-LA neu-
ronal communication by modulating a considerable fraction of 
postsynaptic currents. As justiﬁ  ed below, we interpret this to suggest 
that GABACRs could be located on the presynaptic side on the axons 
of the interneurons and act as autoinhibitors to reduce synaptic 
GABA release. Infusion of GABACR agonists and antagonists in LA 
in conjunction with auditory Pavlovian fear conditioning showed 
that GABAARs and GABACRs play opposing roles in fear acquisi-
tion and consolidation: GABAARs impair and GABACRs enhance 
fear learning and memory. Our results demonstrate a novel role of 
GABACRs, which advances our understanding of the function of 
GABACRs in the brain, our knowledge of the circuitry of the LA, and 
the mechanisms by which fear memories are formed and stored.
IN VITRO PATCH CLAMP RECORDINGS
Previous studies noted the existence of GABACRs in the lateral part 
of the CE (Delaney and Sah, 1999). If GABACRs are also present in 
the LA, their activation would be expected to inﬂ  uence the ampli-
tudes of postsynaptic currents that are evoked by electric stimula-
tion. To test this we used coronal slices that included the LA since 
inhibitory responses of neurons are known to be stronger than in 
horizontal slices (Samson et al., 2003). Pyramidal cell afferents from 
the cortex and thalamus were stimulated electrically. This simul-
taneously elicits monosynaptic EPSCs, through direct activation 
of excitatory thalamic and cortical afferents onto LA pyramidal 
cells, and heterosynaptic through a direct stimulation, and IPSCs, 
FIGURE 2 | Paired pulse depression was affected by muscimol and TPMPA 
Testing for paired pulse depression (PPD) in 12 Pyramidal cells by using an 
interstimulus interval of 100 ms. TPMPA increased the PPD of EPSCs by 
35.6 ± 7 .3% (p < 0.05). Muscimol signiﬁ  cantly increased the PPD ratio and of 
IPSCs by 42.5 ± 5.2% (p < 0.05) and increased the PPF ratio of EPSCs by 
39.2 ± 3.9% (p < 0.05).
FIGURE 3 | Design of in vivo behavior experiments. Outline of general 
behavioral procedures and timing of pre-training injections relative to training.Frontiers in Behavioral Neuroscience  www.frontiersin.org  March  2010 | Volume  4 | Article  6 | 6
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through indirect afferent activation of GABAergic interneurons. An 
increase of the excitatory amplitudes of the postsynaptic currents 
in the presence of muscimol at low concentrations (see above) was 
regarded as an indication of the expression of GABACRs by the 
presynaptic interneurons to the pyramidal cells. In addition, these 
results demonstrate that GABACRs activation reduces feed forward 
FIGURE 4 | Intracranial injections of 0.03 nM muscimol into the LA 
enhanced fear learning and memory. (A) Image shows the mean ± SE 
percent freezing during the test tone presentations for rats injected before 
conditioning with 0.03 nM muscimol (n = 6) and saline (n = 7). (B–D) 
Diagrams show a signiﬁ  cant difference between the control (vehicle 
injection) and muscimol groups for FC, fear conditioning; STM, 
short-term memory test; and LTM, long-term memory test 
(p < 0.05).
FIGURE 5 | Intracranial injections of 30 nM TPMPA into the LA impaired fear learning and memory. (A) Whole experiment with mean ± SE percent freezing 
levels for injections of 30 nM TPMPA (n = 7) and control (n = 6). (B–D) Diagrams show TPMPA impaired fear learning for FC, fear conditioning; STM, short-term 
memory test; and LTM, long-term memory test (p < 0.05).Frontiers in Behavioral Neuroscience  www.frontiersin.org  March  2010 | Volume  4 | Article  6 | 7
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or feedback inhibition and enhances excitatory  transmission. Such 
an effect of muscimol was observed in all of the recorded pyrami-
dal cells.
To answer the question of whether endogenous activation of 
GABACRs contributes to information processing within the LA, the 
speciﬁ  c GABACR blocker TPMPA (Ragozzino et al., 1996; Bormann, 
2000) was applied and the effects on evoked postsynaptic responses 
of pyramidal cells were investigated. If the GABACRs are located on 
the presynaptic interneurons their blockade should increase inhibi-
tion of the pyramidal cells due to higher GABA release. This effect 
was registered in all 14 pyramidal cells we recorded from.
Next we examined PPD and PPF of IPSCs and EPSCs in the 
presence of TPMPA, and separately muscimol (Figure 2). TPMPA 
blocked the GABACRs on the presynaptic side so that during the 
second pulse GABA was still being released. The second pulse 
showed a stronger reduction of excitation, which was recorded as 
smaller EPSCs (PPD). On the other hand, muscimol application 
activated the presynaptic GABACRs. During the second pulse the 
IPSC amplitudes were decreased (PPD) and EPSCs increased (PPF). 
This was a result of suppressed GABA release.
These results lead us to the conclusion that GABACRs could 
be located on the presynaptic side. We propose in our model that 
GABACRs would act as autoinhibitors on interneurons (Figure 6). 
A similar function for GABACRs was described in the retina, where 
GABACRs are expressed predominantly at the bipolar cell terminals 
wherefrom they mediate feedback inhibition from amacrine cells 
(Lukasiewicz and Werblin, 1994; Vaquero and de la Villa, 1999; 
Euler and Masland, 2000; Shields et al., 2000). In general inhibi-
tion mediated by GABACRs is slower compared to the kinetics of 
GABAARs, which induce much faster responses to GABA, suppress 
glutamate release more rapidly and transiently (Pan and Lipton, 
1995). The presence of the three receptor types on the synapse leads 
to a much larger dynamic range in the overall response to GABA 
than each subtype alone.
In our model muscimol or GABA would activate the GABACRs 
on the axons of the interneurons, which would lead to less or no 
GABA release that would inhibit the Pyramidal cells. Application 
of TPMPA would block the presynaptic GABACRs, the axon would 
release GABA which activates the GABAARs and GABABRs that 
inhibit the Pyramidal cells.
IN VIVO AUDITORY PAVLOVIAN FEAR CONDITIONING
LA is a key site of plasticity underlying fear learning (LeDoux, 2000; 
Blair et al., 2001; Maren and Quirk, 2004). It is known that inhibi-
tory circuits in LA and related amygdala areas play an important 
role in fear memory and its extinction (Wilensky et al., 1999; Akirav 
and Richter-Levin, 2006; Zhang and Cranney, 2008). Most studies 
have focused on GABAARs, and to a lesser degree and GABABRs. 
GABAARs have a very large chloride channel (Farrant and Nusser, 
2005), and drugs targeting this receptor produce strong cellular 
hyper polarization and have a profound impact on processing in 
neural circuits.
Our physiological results in coronal slices suggest that GABACRs 
could be present in the LA on the presynaptic terminals of inhibi-
tory inputs onto pyramidal cells, and act as autoinhibitors on the 
interneurons. If our interpretation is accurate, their activation 
should also inﬂ  uence fear learning and memory.
To test this we examined the effects of intra-LA infusion of a 
GABACR agonist and antagonist on auditory Pavlovian fear con-
ditioning. Previously 4.4 nM muscimol was used as a GABAAR 
agonist (Wilensky et al., 1999). It is known that GABACR are at 
least 10-fold more sensitive to GABA and muscimol than GABAARs 
(Bormann, 2000). We used 0.03 nM muscimol as a GABACR ago-
nist, and found a signiﬁ  cant difference to the control (Figure 4) for 
FC, STM, and LTM. We found that activation of GABACRs with low 
concentrations of muscimol enhanced fear learning and memory 
and that blocking GABACRs with TPMPA produced the opposite 
effect (Figure 5). These results showed two things: (1) GABACRs 
modulates fear acquisition and consolidation; and (2) the role of 
GABACRs is opposite from GABAARs: their activation enhances 
fear learning and memory.
IMPLICATIONS FOR ANXIETY DISORDERS
GABAergic agonists (e.g., benzodiazepines), are commonly used 
drugs to treat anxiety-related disorders, especially by targeting 
GABAARs. Yet, beyond their potent anxiolytic properties, these 
drugs also lead to side effects that include sedation, motor and 
memory impairments. These side effects are, in part, due to the 
fact that GABAARs are ubiquitously distributed throughout the 
mammalian brain. Another problem is that these drugs often 
lead to dependence. A third problem is that GABAARs desensi-
tize, possibly explaining why patients with generalized anxiety 
disorder or panic disorder show lower benzodiazepine binding in 
some forebrain areas (Kaschka et al., 1995; Tiihonen et al., 1997; 
Malizia et al., 1998). Due to the non-speciﬁ  c effects of benzodi-
azepines, their potential for dependence, and their tendency to 
desensitize, GABAARs are not optimal as a target for long-term 
FIGURE 6 | Model for our hypothesis: GABACRs are located on the 
presynaptic side. Based on our results with GABACRs ago- and antagonists 
we assume that the receptors are located on the presynaptic side and act as 
autoinhibitors on the interneurons in the LA.Frontiers in Behavioral Neuroscience  www.frontiersin.org  March  2010 | Volume  4 | Article  6 | 8
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Distinct ionotropic GABA receptors 
mediate presynaptic and  postsynaptic 
  inhibition in retinal bipolar cells. J. 
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in the brain. Annu. Rev. Neurosci. 23, 
155–184.
Lukasiewicz, P. D., Maple, B. R., and 
Werblin, F. S. (1994). A novel GABA 
receptor on bipolar cell terminals in 
the tiger salamander retina. J. Neurosci. 
14, 1202–1212.
Lukasiewicz, P. D., and Werblin, F. S. 
(1994). A novel GABA receptor modu-
lates synaptic transmission from bipo-
lar to ganglion and amacrine cells in 
the tiger salamander retina. J. Neurosci. 
14, 1213–1223.
Malizia, A. L., Cunningham, V. J., Bell, C. 
J., Liddle, P. F., Jones, T., and Nutt, D. 
J. (1998). Decreased brain GABA(A)-
benzodiazepine receptor binding in 
panic disorder: preliminary results 
from a quantitative PET study. Arch. 
Gen. Psychiatry 55, 715–720.
Maren, S., and Quirk, G. J. (2004). 
Neuronal signalling of fear memory. 
Nat. Rev. Neurosci. 5, 844–852.
McGaugh, J. L. (2000). Memory – a century 
of consolidation. Science 287, 248–251.
Monk, C. S. (2008). The development 
of emotion-related neural circuitry 
in health and psychopathology. Dev. 
Psychopathol. 20, 1231–1250.
Nader K., and LeDoux, J. (1999). The 
dopaminergic modulation of fear: 
quinpirole impairs the recall of 
emotional memories in rats. Behav. 
Neurosci. 113, 152–165.
Nicoll, R. A., Malenka, R. C., and Kauer, J. 
A. (1990). Functional comparison of 
neurotransmitter receptor subtypes in 
mammalian central nervous system. 
Physiol. Rev. 70, 513–565.
Pan, Z. H., and Lipton, S. A. (1995). 
Multiple GABA receptor subtypes 
mediate inhibition of calcium inﬂ  ux 
at rat retinal bipolar cell terminals. J. 
Neurosci. 15, 2668–2679.
Pasternack, M., Boller, M., Pau, B., and 
Schmidt, M. (1999). GABA(A) and 
treatment of patients with anxiety disorders. As a result, there 
has been a continued search for new, more speciﬁ  c, anxiolytic 
agents, either by indirect modulation of GABAARs via targeting 
norepinephrine (NE), serotonin, and dopamine, or by research 
aimed at altering speciﬁ  c GABAARs subunits. Given that amy-
gdala processing is altered in anxiety disorders (LeDoux, 2007; 
Monk, 2008), our results suggest that GABACRs in the amygdala 
might be useful alternative target for the development of anti-
anxiety drugs.
CONCLUSION
The present results expand our understanding of the role of GABA 
receptors in fear learning, and suggest possible ways to improve the 
treatment of anxiety-related disorders. However further studies are 
needed to fully understand the role of GABACRs in the   amygdala, 
where neuromodulators like NE play crucial roles in synaptic 
 plasticity and learning and memory (Cahill et al., 1994; McGaugh, 
2000; Debiec and Ledoux, 2004). The GABAARs antagonist, picro-
toxin, and high dosages of muscimol, which target GABAARs, are 
known to modulate the NE levels in the amygdala (Hatﬁ  eld et al., 
1999). It would be very important to know if and how GABACRs 
agonists and antagonists inﬂ  uence NE and other neuromodulator 
concentrations in the LA.
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